Apricus Wealth, LLC Relmada Therapeutics, Inc. Transaction History
Apricus Wealth, LLC
- $140 Million
- Q1 2024
A detailed history of Apricus Wealth, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Apricus Wealth, LLC holds 78,862 shares of RLMD stock, worth $314,659. This represents 0.26% of its overall portfolio holdings.
Number of Shares
78,862
Previous 78,862
-0.0%
Holding current value
$314,659
Previous $326,000
12.27%
% of portfolio
0.26%
Previous 0.25%
Shares
6 transactions
Others Institutions Holding RLMD
# of Institutions
98Shares Held
14.2MCall Options Held
82KPut Options Held
73.9K-
Vanguard Group Inc Valley Forge, PA1.26MShares$5.01 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.24MShares$4.95 Million0.19% of portfolio
-
Vestal Point Capital, LP New York, NY1.2MShares$4.79 Million0.46% of portfolio
-
Acadian Asset Management LLC Boston, MA1.18MShares$4.71 Million0.02% of portfolio
-
Parsons Capital Management Inc976KShares$3.89 Million0.2% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $114M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...